Showing 541 - 560 results of 66,213 for search '(( 50 ((((ng decrease) OR (a decrease))) OR (nn decrease)) ) OR ( 5 c decrease ))', query time: 1.24s Refine Results
  1. 541
  2. 542

    Decrease in cell viability by siRNA and miRNA dependent induction of DTA. by Liraz Harel (675561)

    Published 2014
    “…<p>U251 cells were transfected with the indicated construct (50 ng) with (A) or without (B) siRNAs (10pmol). …”
  3. 543
  4. 544
  5. 545
  6. 546

    CRISPR/Cas9-mediated deletion of <i>c-REL</i> results in a decreased proliferation of HeLa Kyoto cell accompanied by strongly reduced amounts of histone H2B. by Carsten Slotta (4326091)

    Published 2017
    “…<b>B:</b> Flow cytometric DNA content measurements of DAPI-stained <i>c-REL</i> knockout cells showed a decrease in the amount of mitotic cells in <i>c-REL</i> knockout cells compared to wildtype. …”
  7. 547

    Activation of AKT, decrease in FOXO and activation of glycolytic genes in CERT heterozygous mice. by Niraj K. Nirala (424266)

    Published 2013
    “…Comparison of different FOXO in liver tissue of wild type (+/+) and CERT heterozygous (+/−) mice shows significant decrease in their transcript levels. (C). Comparison of glycolytic genes in skeletal muscle from wild type (+/+) and CERT heterozygous (+/−) mice shows greater than 5 fold increase in transcript levels of phosphoglycerate mutase and pyruvate kinase and 1.8 fold increase in hexokinase. …”
  8. 548

    CNP decrease mitochondrial membrane potential and induce mitochondrial fragmentation in melanoma cells. by Elif Aplak (7430123)

    Published 2020
    “…<p>A, 300 μM CNP (4 h) significantly decreased mitochondrial membrane potential in A375 cells, but not in melanocytes, indicated by changes of TMRM dependent fluorescence in mitochondria. …”
  9. 549
  10. 550

    Decreased capillary density and cardiac fibrosis in <i>Nkx2.5-Cre/Foxm1<sup>fl/fl</sup></i> heart. by Craig Bolte (299486)

    Published 2013
    “…Capillary density was decreased in <i>Nkx2.5-Cre/Foxm1<sup>fl/fl</sup></i> hearts at P11 (A–B, I), while coronary vessel formation was not altered (C–D). …”
  11. 551
  12. 552

    SPL treatment decreases diabetes-induced decrement in protein expression of cldn-5 in glomeruli (GL) and cldn-2 and occldn in proximal tubules (PT). by Eduardo Molina-Jijón (4020464)

    Published 2017
    “…<p>SPL prevents diabetes-induced decrease of cldn-5 protein expression (A and B) in GL, and mRNA (F) and protein expression of cldn-2 (A and C), and protein expression of occldn (A and D) in PT (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0177362#pone.0177362.s002" target="_blank">S2 Fig</a>). …”
  13. 553

    Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

    Published 2016
    “…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”
  14. 554
  15. 555
  16. 556
  17. 557
  18. 558
  19. 559
  20. 560